The first new pill for pattern baldness in almost three decades is moving closer to the market after a positive late-stage trial.
Drug developer Veradermics said on Monday (Tuesday AEDT) that its experimental pill, VDPHL01, met the main goals in a study of 536 men with mild-to-moderate hair loss. The medicine is an extended-release version of minoxidil, the main ingredient in the popular topical treatment Rogaine.
Gift articles to anyone you choose each month when you subscribe.
